, 2019 Subject Explanation and analysis of Management for second quarter 2019 Attention Directors and manager The Stock Exchange of Thailand Inter pharma Public Company Limited (“the Company”) would like
analysis for the three-month period ended September 30, 2019 To: Director and Manager of the Stock Exchange of Thailand Referring to the submission of reviewed financial statements for quarter 3/2019 of Wiik
the 3rd quarter ended 30 September 2019 Attn: Director and Manager, The Stock Exchange of Thailand With respect to the financial information for the 3rd quarter ended 30 September 2019, as submitted by
Ended Dec 31, 2019 operating results that posted a difference greater than 20% To Director and Manager the Stocks Exchange of Thailand Currently, only Thailand Public Company Limited is a manufacturer and
ที่ กม (Translation) No. Gor. Mor. 38/2560 August 8, 2017 Subject: Approve investment in International Commercial Coordination (Hong Kong) Ltd., which is a connected person To : Director and Manager
นาสูความเปนเลิศ ทั้งในดานพาณิชยและคุณภาพผลิตภัณฑอยางเปนมืออาชพี” February 28, 2018 Subject: Clarification on the cause of changes in operating results over 20 percent. To: Director and Manager
1st quarter ended 31 March 2019 Attn: Director and Manager, The Stock Exchange of Thailand With respect to the financial information for the 1st quarter ended 31 March 2019, as submitted by the Company
October 2018 Subject: Clarification of 1st Quarter 2019 operating results that posted a difference greater than 20% from the preceding year To: Director and Manager the Stocks Exchange of Thailand World
August 13 ,2020 Dear Director and The Manager of SET Re: Clarification on the Operating Result of Quarter 2/2020 Thailand economy’s condition of the quarter 2/2563 had a tendency to severely shrink
May 7 ,2020 Dear Director and The Manager of SET Re: Clarification on the Operating Result of Quarter 1/2020 and the Appointment of Auditor Thai economy of quarter 1/2020 tends to shrink from the